|
Myeloid Neoplasia
Citations 31-40 of 176 total displayed.
|
Past content
(since Jan 2009):
|
High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia
- Ruoping Tang, Pierre Hirsch, Fanny Fava, Simona Lapusan, Christophe Marzac, Irène Teyssandier, Julia Pardo, Jean-Pierre Marie, and Ollivier Legrand
Blood 2009; 114: 2993-3000.
[Abstract]
[Full text]
[PDF]
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status
- Fernando P. G. Silva, Sigrid M. A. Swagemakers, Claudia Erpelinck-Verschueren, Bas J. Wouters, Ruud Delwel, Harry Vrieling, Peter van der Spek, Peter J. M. Valk, and Micheline Giphart-Gassler
Blood 2009; 114: 3001-3007.
[Abstract]
[Full text]
[PDF]
Role of leukemia cell invadosome in extramedullary infiltration
- Michael Stefanidakis, Katja Karjalainen, Diana E. Jaalouk, Carl G. Gahmberg, Susan O'Brien, Renata Pasqualini, Wadih Arap, and Erkki Koivunen
Blood 2009; 114: 3008-3017.
[Abstract]
[Full text]
[PDF]
In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm
- Jonathan R. Lambert, Tamara Everington, David C. Linch, and Rosemary E. Gale
Blood 2009; 114: 3018-3023.
[Abstract]
[Full text]
[PDF]
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
- Claudia Haferlach, Cristina Mecucci, Susanne Schnittger, Alexander Kohlmann, Marco Mancini, Antonio Cuneo, Nicoletta Testoni, Giovanna Rege-Cambrin, Antonella Santucci, Marco Vignetti, Paola Fazi, Maria Paola Martelli, Torsten Haferlach, and Brunangelo Falini
Blood 2009; 114: 3024-3032.
[Abstract]
[Full text]
[PDF]
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells
- Yanina Eberhard, Sean P. McDermott, Xiaoming Wang, Marcela Gronda, Amudha Venugopal, Tabitha E. Wood, Rose Hurren, Alessandro Datti, Robert A. Batey, Jeffrey Wrana, William E. Antholine, John Dick, and Aaron D. Schimmer
Blood 2009; 114: 3064-3073.
[Abstract]
[Full text]
[PDF]
Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib
- Richard D. Press, Stephanie G. Willis, Jennifer Laudadio, Michael J. Mauro, and Michael W. N. Deininger
Blood 2009; 114: 2598-2605.
[Abstract]
[Full text]
[PDF]
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- Warren Fiskus, Yongchao Wang, Arun Sreekumar, Kathleen M. Buckley, Huidong Shi, Anand Jillella, Celalettin Ustun, Rekha Rao, Pravina Fernandez, Jianguang Chen, Ramesh Balusu, Sanjay Koul, Peter Atadja, Victor E. Marquez, and Kapil N. Bhalla
Blood 2009; 114: 2733-2743.
[Abstract]
[Full text]
[PDF]
RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia
- Holly Edwards, Chengzhi Xie, Katherine M. LaFiura, Alan A. Dombkowski, Steven A. Buck, Julie L. Boerner, Jeffrey W. Taub, Larry H. Matherly, and Yubin Ge
Blood 2009; 114: 2744-2752.
[Abstract]
[Full text]
[PDF]
Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome
- Diane C. Cabelof, Hiral V. Patel, Qing Chen, Holly van Remmen, Larry H. Matherly, Yubin Ge, and Jeffrey W. Taub
Blood 2009; 114: 2753-2763.
[Abstract]
[Full text]
[PDF]
|
|
